Thermodynamic properties, decomposition kinetics of 2-(5-amino-2H-tetrazol-1-yl)-4-amine-3,5-dinitropyridine

被引:6
|
作者
Hao, Lina [1 ]
Liu, Xuqin [1 ]
Zhai, Diandian [1 ]
Ma, Congming [1 ,2 ]
Ma, Peng [1 ]
Pan, Yong [1 ]
Jiang, Juncheng [1 ]
机构
[1] Nanjing Tech Univ, Coll Safety Sci & Engn, Nanjing 211816, Peoples R China
[2] Wisdom Pharmaceut Co Ltd, Rugao, Jiangsu, Peoples R China
关键词
2-(5-amino-2H-tetrazol-1-yl)-4-amine-3; 5-dinitropyridine (ATDP); Thermal analysis; Density functional theory; Detonation performance; NITROGEN-RICH; DETONATION PROPERTIES; HEATS; ENERGY; PREDICTION;
D O I
10.1007/s00894-022-05066-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A novel energetic material 2-(5-amino-2H-tetrazol-1-yl)-4-amine-3,5-dinitropyridine (ATDP) was synthesized and characterized by H-1 NMR, C-13 NMR, mass spectroscopy, and elemental analysis. The research by differential scanning calorimetry (DSC) shows that ATDP decomposed about 290 degrees C. The calculating results of kinetic parameters using Ozawa method, Kissinger method, and Starink method were quite consistent. Self-accelerated decomposition temperature (T-SADT), thermal ignition temperature (T-TIT), and critical temperature of thermal explosion (T-b) were 272.55 degrees C, 121.71 degrees C, and 137.67 degrees C, respectively. Geometric optimization, heat of formation, detonation velocity (D), detonation pressure (P), bond dissociation energy (BDE), and electrostatic potential (ESP) were explored using Gaussian 16. The results show that ATDP has a much larger Delta H-f,H-gas value than HMX(272.6 kJ mol(-1)). The D and P are predicted with the value of 7.50 km s(-1) and 24.47 GPa, respectively. The relatively high BDE value (270.77 kJ mol(-1)) indicates that ATDP has moderate thermal stability.
引用
收藏
页数:9
相关论文
共 45 条
  • [41] Synthesis and Biological Evaluation of the 1-Arylpyrazole Class of σ1 Receptor Antagonists: Identification of 4-{2-[5-Methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862)
    Luis Diaz, Jose
    Cuberes, Rosa
    Berrocal, Joana
    Contijoch, Montserrat
    Christmann, Ute
    Fernandez, Ariadna
    Port, Adriana
    Holenz, Jorg
    Buschmann, Helmut
    Laggner, Christian
    Teresa Serafini, Maria
    Burgueno, Javier
    Zamanillo, Daniel
    Merlos, Manuel
    Miguel Vela, Jose
    Almansa, Carmen
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (19) : 8211 - 8224
  • [42] Experimental and theoretical studies of (FTIR, FT-NMR, UV-Visible, X-ray and DFT) 2-(4-Allyl-5-pyridin-4-yl-4H-[1,2,4]triazol-3-ylsulfanyl)-1-(3-methyl-3-phenyl-cyclobutyl)-ethanone
    Ataol, Cigdem Yuksektepe
    Ekici, Oner
    JOURNAL OF MOLECULAR STRUCTURE, 2014, 1065 : 1 - 9
  • [43] Biotransformation of 4-fluoro-N-(1-{2-[(propan-2-yl)phenoxy]ethyl}-8-azabicyclo[3.2.1]octan-3-yl)-benzenesulfonamide, a novel potent 5-HT7 receptor antagonist with antidepressant-like and anxiolytic properties: In vitro and in silico approach
    Sloczynska, Karolina
    Wojcik-Pszczola, Katarzyna
    Canale, Vittorio
    Zmudzki, Pawel
    Zajdel, Pawel
    Pekala, Elzbieta
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2018, 32 (05)
  • [44] Synthesis, crystal structure analysis, spectral investigations (NMR, FT-IR, UV), DFT calculations, ADMET studies, molecular docking and anticancer activity of 2-(1-benzyl-5-methyl-1H-1,2,3-triazol-4-yl)-4-(2-chlorophenyl)-6-methoxypyridine - A novel potent human topoisomerase IIα inhibitor
    Murugavel, S.
    Ravikumar, C.
    Jaabil, G.
    Alagusundaram, Ponnusamy
    JOURNAL OF MOLECULAR STRUCTURE, 2019, 1176 : 729 - 742
  • [45] Optimization of a Novel Binding Motif to (E)-3-(3,5-Difluoro-4-((1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)phenyl)acrylic Acid (AZD9496), a Potent and Orally Bioavailable Selective Estrogen Receptor Downregulator and Antagonist
    De Savi, Chris
    Bradbury, Robert H.
    Rabow, Alfred A.
    Norman, Richard A.
    de Almeida, Camila
    Andrews, David M.
    Ballard, Peter
    Buttar, David
    Callis, Rowena J.
    Currie, Gordon S.
    Curwen, Jon O.
    Davies, Chris D.
    Donald, Craig S.
    Feron, Lyman J. L.
    Gingell, Helen
    Glossop, Steven C.
    Hayter, Barry R.
    Hussain, Syeed
    Karoutchi, Galith
    Lamont, Scott G.
    MacFaul, Philip
    Moss, Thomas A.
    Pearson, Stuart E.
    Tonge, Michael
    Walker, Graeme E.
    Weir, Hazel M.
    Wilson, Zena
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (20) : 8128 - 8140